Advertisement
News
Advertisement

U.S. to begin safety testing Ebola vaccine next week

Thu, 08/28/2014 - 9:25am
Seth Borenstein - AP Science Writer - Associated Press

 
              FILE - This Aug. 12, 2014 file photo shows a healthcare worker walking near a Ebola isolation unit wearing protective gear against the virus at Kenema Government Hospital in Kenema, Sierra Leone. Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus. The National Institutes of Health (NIH) announced Thursday that it is launching the safety trial on a vaccine developed by the agency’s National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. They will test 20 healthy adult volunteers to see if the virus is safe and triggers an adequate response in their immune systems. (AP Photo/ Michael Duff, File)

Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus.

The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. It will test 20 healthy adult volunteers to see if the virus is safe and triggers an adequate response in their immune systems.

That testing will be at NIH's campus in Bethesda, Md. Later in September, NIH and a British team will test that vaccine on volunteers in the U.K., Gambia and Mali.

American health officials are also talking about a future trial in Nigeria.

So far Ebola has killed 1,552 people in West Africa.

Advertisement

Share This Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading